Oncologists are capable of some raucous applause, but they don’t bestow it upon just anyone. Today saw one of those coveted ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. The French pharma company Servier ...

A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse population.

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies ...

Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost ...

The company behind the analytics, Vizient, touts MGH's increasing hospice enrollment to improved mortality performance.

A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor ...

That’s how many patients with Covid-19 go on to develop long Covid, according to a study of nearly 458,000 patients at 58 hospitals, published yesterday in JAMA Network Open. It’s about twice the rate ...

NAIROBI, Kenya — A court in Kenya on Friday suspended a U.S. plan to establish a quarantine facility for Americans exposed to a rare type of Ebola virus spreading in northeastern Congo, following a ...